About UVS
UVS is a Healthcare company based in Reykjavik (Iceland) founded in 1999, and was acquired by deCODE Genetics in January 2006. Cancer research is conducted via population genomic studies. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
UVS was founded in 1999 in Reykjavik, Iceland, within the biotechnology sector. Population genomic studies are employed to advance cancer research, with high-throughput sequencing methods applied to analyze the Icelandic population for inherited cancer-related genes like BRCA1 and BRCA2. Operations focus on biomarker discovery and support targeted drug development in oncology.
- Headquarters Reykjavik, Iceland
- Stage Acquired
- SectorsHealthcare
- Website uvs.is
- Acquired by deCODE Genetics (Jan 2006)
- Investors
- Acquired bydeCODE Genetics
(Jan 2006)
Investors in UVS
UVS has secured backing from 1 investor. Prominent investors backing the company include deCODE Genetics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bioinformatics platform for genetic disease analysis is provided. | 1996 | decode.com | Reykjavik, Iceland |
Investor details for UVS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of UVS
2 dated milestones of UVS across 7 years, from founding to its latest funding, stage changes and deals.
- Founded UVS is founded.
- Exit Acquired by deCODE Genetics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about UVS
UVS was founded in 1999.
UVS is headquartered in Reykjavik, Iceland.
UVS was founded in 1999 in Reykjavik, Iceland, within the biotechnology sector. Population genomic studies are employed to advance cancer research, with high-throughput sequencing methods applied to analyze the Icelandic population for inherited cancer-related genes like BRCA1 and BRCA2. Operations focus on biomarker discovery and support targeted drug development in oncology.
UVS has 1 investor. Key investors include deCODE Genetics.
Yes. UVS was acquired by deCODE Genetics in January 2006.